U.S. markets closed

cbdMD, Inc. (YCBD)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4300-0.0102 (-2.32%)
At close: 04:00PM EDT
0.4590 +0.03 (+6.74%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close0.4402
Bid0.4300 x 2200
Ask0.4500 x 1000
Day's Range0.4300 - 0.4641
52 Week Range0.4100 - 3.0200
Avg. Volume263,130
Market Cap25.775M
Beta (5Y Monthly)1.68
PE Ratio (TTM)N/A
EPS (TTM)-0.5030
Earnings DateAug 10, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for YCBD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • cbdMD, Inc.
    Daily – Vickers Top Buyers & Sellers for 10/15/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    9 months agoArgus Research
View more
  • Newsfile

    cbdMD's Dr. Sibyl Swift Provides Testimony To the FDA Science Board on Proper Safety Methods for CBD Products

    Charlotte, North Carolina--(Newsfile Corp. - June 29, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized health and wellness companies, presented testimony at the public advisory committee meeting of the Science Board to the Food and Drug Administration (FDA) held earlier in June. The Company's V.P. of Science and Regulatory Affairs, Dr. Sibyl Swift, was invited to present testimony related to the ...

  • American City Business Journals

    cbdMD CEO, board member Marty Sumichrast resigns with $590K severance following SEC lawsuit

    Marty Sumichrast has resigned as CEO, board member and an employee of cbdMD Inc. less than two weeks after federal regulators sued him, alleging fraud and self-dealing at a Charlotte investment firm he once ran.

  • Newsfile

    cbdMD, Inc. CEO Steps Down

    Martin Sumichrast resigns as CEO, Board Member Charlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), announced today that Martin Sumichrast has resigned as CEO and member of the Board of Directors, effective immediately. Board member Scott Stephen was named Board Chair and board member Scott Coffman, former co-CEO and the operating company founder, will consult with the Board of Directors in leading the company until a ...